
Wednesday, September 21, 2016 10:16:55 AM
Peregrine Pharmaceuticals Provides Update on Oral Presentation of Top-Line Data from Phase III SUNRISE Trial of Bavituximab
Already up over 30% within the first 30 minutes of trading!
We could see similar results when our TOP LINE Data is released!
Best of Luck!
In My Own Personal Opinion Of Course!

Liked By
Spread the love. Be the first to like this post!
Recent PTN News
- Frontiers in Immunology Publishes Pre-Clinical Study of Palatin's Oral Formulation of PL8177 Demonstrating Therapeutic Effects in Inflammatory Bowel Disease • PR Newswire (US) • 03/02/2023 12:30:00 PM
- Palatin Issued Patent on Vyleesi® (Bremelanotide Injection) For Hypoactive Sexual Desire Disorder in Patients With Controlled Hypertension • PR Newswire (US) • 02/28/2023 12:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/15/2023 01:27:30 PM
- Palatin Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update • PR Newswire (US) • 02/15/2023 12:30:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 02/14/2023 09:50:20 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/14/2023 06:20:30 PM
- Palatin to Report Second Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on February 15, 2023 • PR Newswire (US) • 02/10/2023 12:30:00 PM
- Palatin Initiates Enrollment in the Phase 2 Bremelanotide BREAKOUT Study in Patients with Diabetic Kidney Disease • PR Newswire (US) • 01/19/2023 12:30:00 PM
- Palatin Receives $4.7 Million of Non-Dilutive Funding • PR Newswire (US) • 01/18/2023 12:30:00 PM
- Frontiers in Immunology Publishes Pre-Clinical Study of Palatin's PL8177 Demonstrating Therapeutic Effects in Inflammatory Conditions • PR Newswire (US) • 01/10/2023 12:30:00 PM
- Palatin Announces Preliminary Second Quarter Fiscal 2023 Vyleesi® Product Sales Results • PR Newswire (US) • 01/05/2023 12:30:00 PM
- Amended Statement of Changes in Beneficial Ownership (4/a) • Edgar (US Regulatory) • 12/28/2022 03:30:29 PM
- Amended Statement of Changes in Beneficial Ownership (4/a) • Edgar (US Regulatory) • 12/28/2022 03:30:23 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/23/2022 10:31:40 PM
- Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Palatin Technologies (PTN) • TipRanks • 11/15/2022 12:05:42 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 09:51:21 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/14/2022 01:02:39 PM
- Palatin Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update • PR Newswire (US) • 11/14/2022 12:30:00 PM
- Palatin to Report First Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on November 14, 2022 • PR Newswire (US) • 11/09/2022 10:16:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/02/2022 09:08:25 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 11/02/2022 02:37:31 PM
- Palatin Announces $10 Million Registered Direct Offering • PR Newswire (US) • 10/31/2022 01:30:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 10/25/2022 09:02:40 PM
- Palatin Presents PL8177 Data at American College of Gastroenterology Annual Meeting • PR Newswire (US) • 10/24/2022 09:32:00 PM
- First Patient Enrolled in Palatin's Phase 2 study of PL8177 in Ulcerative Colitis Trial • PR Newswire (US) • 10/20/2022 11:30:00 AM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM
Memorandum of Understanding With Miranda Water Treatment Systems and Rainmaker Worldwide Inc. Extended • RAKR • Mar 27, 2023 8:50 AM
Hollywall Entertainment Inc., (OTC:HWAL) Announces the completion of its 2021 and 2020 Audit (s) • HWAL • Mar 24, 2023 12:48 PM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM